Cognetivity Neurosciences Ltd.
CGNSFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$8959
P/E Ratio—
52W High$0.0019
52W Low$0.0001
Cognetivity Neurosciences Ltd. (CGNSF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CGNSF · earnings · updated Jun 8, 2026
Latest Earnings
Q4 FY2023Report Date: Dec 29, 2023EPS Actual
-$0.02
Est. -$0.01 · -16.2%
Revenue
$0.00B
Est. $0.00B · -90.6%
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Dec 29, 2023
After Market Close
▼ Miss EPS▼ Miss Revenue
CGNSF reports quarterly as a OTC-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 2, 2026 | — | — | — | — | — | — |
| ◌ Q2 FY2026 | Apr 1, 2026 | — | — | — | — | $0.01B | — |
| ◌ Q1 FY2025 | Feb 26, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Dec 27, 2024 | — | — | — | — | — | — |
| ◌ Q3 FY2024 | Sep 27, 2024 | — | — | — | — | $0.00B | — |
| ◌ Q2 FY2024 | Jun 28, 2024 | — | — | — | — | $0.00B | — |
| ◌ Q1 FY2024 | Jan 2, 2024 | — | — | — | — | — | — |
| ▼ Q4 FY2023 | Dec 29, 2023 | -$0.01 | -$0.02 | -16.2% | $0.00B | $0.00B | -90.6% |
Q3 FY2026
Jul 2, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 1, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Feb 26, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 27, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Sep 27, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Jun 28, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Jan 2, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Dec 29, 2023Miss
EPS Actual
-$0.02
EPS Est.
-$0.01
EPS Surpr.
-16.2%
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2023 | Dec 29, 2023 | -16.2% | $0.01 | $0.01 | +27.83% |
| — Q3 FY2023 | Sep 29, 2023 | — | $0.11 | $0.11 | +0.40% |
| ▼ Q2 FY2023 | Jun 29, 2023 | -145.1% | $0.19 | $0.19 | -3.57% |
| — Q1 FY2023 | Jan 31, 2023 | — | $0.18 | $0.18 | +0.00% |
| ▼ Q4 FY2022 | Dec 16, 2022 | -125.9% | $0.20 | $0.18 | -10.72% |
Q4 FY2023+27.83%
Report Date
Dec 29, 2023
EPS Beat/Miss
-16.2%
Price Before
$0.01
Price After
$0.01
Q3 FY2023+0.40%
Report Date
Sep 29, 2023
EPS Beat/Miss
—
Price Before
$0.11
Price After
$0.11
Q2 FY2023-3.57%
Report Date
Jun 29, 2023
EPS Beat/Miss
-145.1%
Price Before
$0.19
Price After
$0.19
Q1 FY2023+0.00%
Report Date
Jan 31, 2023
EPS Beat/Miss
—
Price Before
$0.18
Price After
$0.18
Q4 FY2022-10.72%
Report Date
Dec 16, 2022
EPS Beat/Miss
-125.9%
Price Before
$0.20
Price After
$0.18
Avg Miss Reaction+4.51%
Beat Rate0 / 5 quarters
Largest Move+27.83% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CGNSF ends December
Cognetivity Neurosciences Ltd. (CGNSF) most recently reported earnings on December 29, 2023 for Q4 FY2023, posting EPS of $-0.02 — missing the analyst consensus of $-0.01 by -16.2%. The next CGNSF earnings date is expected around September 1, 2026.
Each quarter, investors track CGNSF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CGNSF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CGNSF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CGNSF earnings · 5 questionsCognetivity Neurosciences Ltd.'s next earnings report is expected around September 1, 2026. CGNSF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CGNSF historically reports after market close (AMC).
CGNSF earnings datewhen is CGNSF earningsCGNSF next earnings datewhen does CGNSF report earningsCGNSF earnings calendar
▸ Source: FMP · Cognetivity Neurosciences Ltd. SEC filings · US GAAP · Cognetivity Neurosciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026